SELLAS Life Sciences Group, Inc. (SLS)
11.34
-0.54
(-4.55%)
USD |
NASDAQ |
Oct 15, 16:00
11.37
+0.03
(+0.26%)
After-Hours: 20:00
SELLAS Life Sciences Group Cash from Operations (TTM) : -28.42M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -28.42M |
| March 31, 2026 | -28.16M |
| December 31, 2025 | -28.39M |
| September 30, 2025 | -30.62M |
| June 30, 2025 | -31.36M |
| March 31, 2025 | -33.71M |
| December 31, 2024 | -35.40M |
| September 30, 2024 | -33.07M |
| June 30, 2024 | -32.16M |
| March 31, 2024 | -30.04M |
| December 31, 2023 | -31.41M |
| September 30, 2023 | -31.74M |
| June 30, 2023 | -30.59M |
| March 31, 2023 | -28.79M |
| December 31, 2022 | -23.81M |
| September 30, 2022 | -23.63M |
| June 30, 2022 | -23.76M |
| March 31, 2022 | -22.90M |
| December 31, 2021 | -26.02M |
| September 30, 2021 | -17.62M |
| June 30, 2021 | -15.37M |
| March 31, 2021 | -13.86M |
| December 31, 2020 | -10.42M |
| September 30, 2020 | -18.02M |
| June 30, 2020 | -18.21M |
| Date | Value |
|---|---|
| March 31, 2020 | -19.48M |
| December 31, 2019 | -17.64M |
| September 30, 2019 | -18.02M |
| June 30, 2019 | -28.37M |
| March 31, 2019 | -30.01M |
| December 31, 2018 | -30.42M |
| September 30, 2018 | -27.61M |
| June 30, 2018 | -15.84M |
| March 31, 2018 | -5.988M |
| December 31, 2017 | -10.99M |
| September 30, 2017 | -17.25M |
| June 30, 2017 | -27.06M |
| March 31, 2017 | -42.10M |
| December 31, 2016 | -44.92M |
| September 30, 2016 | -52.20M |
| June 30, 2016 | -49.45M |
| March 31, 2016 | -49.82M |
| December 31, 2015 | -48.16M |
| September 30, 2015 | -43.62M |
| June 30, 2015 | -45.26M |
| March 31, 2015 | -46.38M |
| December 31, 2014 | -42.87M |
| September 30, 2014 | -40.60M |
| June 30, 2014 | -37.47M |
| March 31, 2014 | -31.62M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| ImmunityBio, Inc. | -281.14M |
| AbbVie, Inc. | 19.51B |
| TG Therapeutics, Inc. | 17.88M |
| Capricor Therapeutics, Inc. | -104.00M |
| Relay Therapeutics, Inc. | -212.20M |